Todd Asset Management LLC Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

Todd Asset Management LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 70,607 shares of the healthcare conglomerate’s stock after purchasing an additional 3,760 shares during the period. Todd Asset Management LLC’s holdings in UnitedHealth Group were worth $37,172,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Bray Capital Advisors increased its holdings in UnitedHealth Group by 0.5% in the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after acquiring an additional 50 shares during the last quarter. Litman Gregory Wealth Management LLC bought a new position in UnitedHealth Group in the 3rd quarter worth approximately $11,680,000. Live Oak Private Wealth LLC raised its holdings in UnitedHealth Group by 0.8% during the 3rd quarter. Live Oak Private Wealth LLC now owns 23,212 shares of the healthcare conglomerate’s stock valued at $11,703,000 after acquiring an additional 179 shares during the period. Hexagon Capital Partners LLC grew its position in shares of UnitedHealth Group by 3.6% in the third quarter. Hexagon Capital Partners LLC now owns 1,083 shares of the healthcare conglomerate’s stock valued at $546,000 after purchasing an additional 38 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. grew its holdings in UnitedHealth Group by 5.4% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 131,333 shares of the healthcare conglomerate’s stock valued at $66,217,000 after buying an additional 6,777 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on UNH shares. Oppenheimer reiterated an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a research report on Wednesday, January 17th. TD Cowen lowered their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Piper Sandler lifted their price target on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Truist Financial restated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Finally, Bank of America reaffirmed a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research note on Thursday, March 7th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Stock Down 0.1 %

UnitedHealth Group stock traded down $0.52 during trading hours on Friday, hitting $492.45. 2,487,811 shares of the stock traded hands, compared to its average volume of 5,130,659. The company has a market cap of $453.09 billion, a PE ratio of 30.10, a PEG ratio of 1.43 and a beta of 0.55. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The firm’s 50-day moving average price is $482.32 and its two-hundred day moving average price is $512.76. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the previous year, the firm earned $6.26 EPS. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.